Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
Drug firm Zydus Cadila on Thursday said it has received final approval from the US health regulator to market Ibrutinib Capsules, used to treat certain cancers
The newly approved medication will be manufactured at the group''s formulation manufacturing facility at SEZ, Ahmedabad
Zydus Wellness will fund its acquisition of Heinz India Pvt Ltd through share sale.